KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-cash Items (2016 - 2018)

Emergent BioSolutions (EBS) has 8 years of Non-cash Items data on record, last reported at $32.8 million in Q4 2018.

  • For Q4 2018, Non-cash Items fell 26.29% year-over-year to $32.8 million; the TTM value through Dec 2018 reached $32.8 million, down 26.29%, while the annual FY2018 figure was $32.8 million, 26.29% down from the prior year.
  • Non-cash Items reached $32.8 million in Q4 2018 per EBS's latest filing, down from $44.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $52.1 million in Q4 2015 and bottomed at $29699.0 in Q2 2015.
  • Average Non-cash Items over 5 years is $18.6 million, with a median of $14.8 million recorded in 2017.
  • Peak YoY movement for Non-cash Items: crashed 98.6% in 2015, then skyrocketed 34642.83% in 2016.
  • A 5-year view of Non-cash Items shows it stood at $29.2 million in 2014, then soared by 78.6% to $52.1 million in 2015, then tumbled by 51.37% to $25.3 million in 2016, then soared by 75.55% to $44.5 million in 2017, then dropped by 26.29% to $32.8 million in 2018.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $32.8 million in Q4 2018, $44.5 million in Q4 2017, and $38.0 million in Q3 2017.